Abstract: The invention relates to the identification and use of the DAF-2/IR responsive sod-3 promoter. Transgenic C. elegans containing sod-3 reporter gene constructs are described which are useful for, among other things, the identification of genes or compounds capable of modulating the DAF-2/IR-akt pathway. Conditions are disclosed that increase or decrease the reporter activity, demonstrating the presence of either activators or inhibitors of the DAF-2/IR pathway.
Type:
Grant
Filed:
January 28, 2004
Date of Patent:
October 14, 2008
Assignee:
Sanofi-Aventis Deutschland GmbH
Inventors:
Edmund Hoppe, Ulrike Siebers, Heike Schauerte, Jonathan Rothblatt